NASDAQ: SRPT · Biotechnology
Over the past week, Sarepta Therapeutics (SRPT) logged about 48 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 46% bullish but is sharply divided: Reddit runs 67% bullish while News sits at just 35%. Wall Street is more cautious, with 8 of 24 analysts rating SRPT a buy.
There is little buzz around SRPT this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 33% buy share sits next to a crowd that ranges from News at 35% to Reddit at 67%. No other tracker puts the two side by side.
24 analysts have weighed in: a Hold consensus: 8 buy calls against 5 sell, with an average 12-month price target of $22.26.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
The crowd runs 13 points hotter than the 33% analyst buy share, retail is ahead of the Street here. The split is inside the crowd: Reddit reads 67% bullish while News sits at 35%, a 32-point spread that single-source trackers miss.
Over the 30-day window, Sarepta Therapeutics (SRPT) buzz held subdued around 34.7 while the price drifted up 11.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.1M shares. Over the last 7 trading days, SRPT lost 11.9%. Buzz activity in the recent week averaged 33.8 and was variable, swinging between 23.0 and 52.5. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 7 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for SRPT and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SRPT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Hold (8 / 11 / 5) |
| Crowd bullish (7d) | 46% |
| Avg price target | $22.26 |
| Most bullish source | Reddit, 67% |
| Most bearish source | News, 35% |
| Sentiment spread | 32 pts |
| Mentions (7d) | 48 |
| Market cap | $2.17B |
| P/E · Forward P/E | n/a · 22.2 |
| EPS · Beta | -$1.57 · 0.3 |
| Revenue (TTM) | $1.97B · -7% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Sarepta Therapeutics (SRPT) currently carries an Adanos hold signal with 65/100 conviction. The current cross-source average reads 46% bullish across 3 active sources. Those sources contribute 48 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Sarepta Therapeutics (SRPT) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 5 tracked subreddits. The 7-day tone is 67% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads split on Sarepta Therapeutics (SRPT), averaging 46% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 67% bullish and News at 35%, a 32-point spread. On the professional side, 8 of 24 analysts rate SRPT a buy.
Of the 24 analysts covering Sarepta Therapeutics (SRPT), 8 rate it a buy, 11 a hold and 5 a sell, for a hold consensus. The average price target is $22.26. The crowd is the more bullish of the two, averaging 46%.
Sarepta Therapeutics (SRPT)'s cross-source average is mixed at 46% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 67% bullish, X reads 36% bullish and news coverage is the most negative at 35% bullish. The combined signal points to broad mixed pressure with 65/100 conviction.
The cross-source average is mixed for Sarepta Therapeutics (SRPT) at 46% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is news at 35% bullish. 3-day activity momentum is falling on X and News, while reddit activity is rising. The hold signal carries 65/100 conviction.
X is the dominant discussion channel with 25 mentions (52% of total volume). News contributes 20 mentions and Reddit contributes 3 mentions. The cross-source average is mixed at 46% bullish, while reddit is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SRPT's hold signal at 65/100 conviction reflects a mixed cross-source average at 46% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The SRPT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key